Successful neuroprotection is only possible with contemporary microvascular protection.
The prevention of disease-induced vascular modifications that accelerate brain damage …

Background People with alcohol use disorder (AUD) may be at higher risk for COVID‐19.
Angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 …

Astrocytes are increasingly recognized as important viral host cells in the central nervous
system. These cells can produce relatively high quantities of new virions. In part, this can be …

Persistent symptoms following COVID-19 infection have been termed postacute sequelae of
severe acute respiratory syndrome coronavirus 2 infection. Many of these symptoms are …

Persistence of symptoms beyond the initial 3 to 4 weeks after infection is defined as post-
acute COVID-19 syndrome (PACS). A wide range of neuropsychiatric symptoms like anxiety …

Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …

The brain renin–angiotensin system (RAS) has recently been implicated in the development
of substance abuse and addiction. However, the integrative roles of the two counter …

The renin–angiotensin system (RAS) is dysregulated in Alzheimer's disease (AD). In this
study, we have explored the hypothesis that an age-related imbalance in brain RAS is a …

Abstract Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to the pulmonary …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the
respiratory system but can also lead to neurological complications. Among COVID-19 …